Illumina Stock Investor Sentiment

ILMN Stock  USD 136.99  5.31  4.03%   
About 56% of all Illumina's investors are looking to take a long position. The analysis of overall sentiment of trading Illumina stock suggests that some investors are interested at this time. Illumina's investing sentiment overview a quick insight into current market opportunities from investing in Illumina. Many technical investors use Illumina stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

56

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Illumina's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Illumina.

Illumina Historical Sentiment

Although Illumina's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Illumina, such as negative comments on social media and news outlets, may cause fear in the market and push Illumina's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Illumina.
  

Illumina Historical Investor Sentiment

Investor biases related to Illumina's public news can be used to forecast risks associated with an investment in Illumina. The trend in average sentiment can be used to explain how an investor holding Illumina can time the market purely based on public headlines and social activities around Illumina. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Illumina's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Illumina and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Illumina news discussions. The higher the estimate score, the more favorable the investor's outlook on Illumina.
20 hours ago at finance.yahoo.com         
Liquid Biopsy Market Size to Worth USD 28.84 Billion by 2033 Straits Research
Yahoo News
a day ago at finance.yahoo.com         
Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progress in Regenerative Medic...
Yahoo News
a day ago at gurufocus.com         
Myriad Genetics Announces Incorporation of its Proprietary HRD p
Gurufocus Stories at Macroaxis
2 days ago at businesswire.com         
Next-Generation Sequencing Industry Research Outlook 2024-2031 Increasing Application of NGS in Pers...
businesswire News
2 days ago at investing.com         
Grails CFO Aaron Freidin sells 426,937 in common stock
Investing News at Macroaxis
2 days ago at finance.yahoo.com         
Global Drug Discovery Technologies Market Projected to Reach 197 Billion by 2029
Yahoo News
3 days ago at finance.yahoo.com         
Is Illumina, Inc. the Best Immunotherapy Stock to Buy Now?
Yahoo News
3 days ago at insidermonkey.com         
Is Illumina, Inc. the Best Immunotherapy Stock to Buy Now?
insidermonkey News
3 days ago at finance.yahoo.com         
Del Mars Last Sandlot Becomes Elevated 75 Million Oceanfront Estate
Yahoo News
few days ago at thelincolnianonline.com         
Illumina Stock Price Expected to Rise, Stephens Analyst Says
news
few days ago at gurufocus.com         
Illumina Inc Trading Down 5.05 percent on Nov 16
Gurufocus Stories at Macroaxis
few days ago at businesswire.com         
Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com
businesswire News
few days ago at thelincolnianonline.com         
Oppenheimer Co. Inc. Has 5.33 Million Stake in Illumina, Inc.
news
six days ago at thelincolnianonline.com         
Illumina Earns Equal Weight Rating from Morgan Stanley
news
six days ago at thelincolnianonline.com         
10,563 Shares in Illumina, Inc. Bought by Entropy Technologies LP
news
Far too much social signal, news, headlines, and media speculation about Illumina that are available to investors today. That information is available publicly through Illumina media outlets and privately through word of mouth or via Illumina internal channels. However, regardless of the origin, that massive amount of Illumina data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Illumina news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Illumina relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Illumina's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Illumina alpha.

Illumina Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Jacob Thaysen of 7426 shares of Illumina subject to Rule 16b-3
09/20/2024
2
Disposition of 914 shares by Jacob Thaysen of Illumina at 140.66 subject to Rule 16b-3
10/04/2024
3
Are You a Momentum Investor This 1 Stock Could Be the Perfect Pick
10/24/2024
4
Illumina earnings beat by 0.26, revenue was in line with estimates
11/04/2024
5
Illumina shares target raised, neutral rating on 3Q update
11/06/2024
6
Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the Healthy China
11/08/2024
7
Morgan Stanley sets Illumina stock target, rates Equalweight on GRAIL resolution
11/12/2024
8
DNA Sequencing Market to Grow by USD 17.34 Billion , Driven by Rising NGS Adoption, AI-Powered Report Explores Market Evolution - Technavio
11/13/2024
9
Piper Sandler Cuts Illumina Price Target to 185.00
11/14/2024
10
Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com
11/15/2024
11
Is Illumina, Inc. the Best Immunotherapy Stock to Buy Now
11/18/2024
12
Myriad Genetics Announces Incorporation of its Proprietary HRD p
11/20/2024
When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
(9.98)
Revenue Per Share
27.654
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0262
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.